Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in TaiwanChi‐Yi Chen, Ming‐Lung Yu, Lee‐Won Chong et al.|Liver International|2021Cited by 57
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)Chung‐Feng Huang, Ming‐Lung Yu, Kuo‐Chih Tseng et al.|Clinical Gastroenterology and Hepatology|2021Cited by 32
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in TaiwanPin‐Nan Cheng, Lein‐Ray Mo, Chun‐Ting Chen et al.|Infectious Diseases and Therapy|2021Cited by 28
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry programMing‐Ying Lu, Chung‐Feng Huang, Chao‐Hung Hung et al.|Clinical and Molecular Hepatology|2023Cited by 26
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in TaiwanChung‐Feng Huang, Ming‐Lung Yu, Hsing‐Tao Kuo et al.|Scientific Reports|2021Cited by 15